April

Articles

MBI announced as Flagship Centre

As part of their 2025 Strategy, the Faculty of Medicine and Health embarked on a review of its Research Centres to determine where they should strategically focus their research support and investment.

Cryptococcal Antigen in Serum and Cerebrospinal Fluid for Detecting Cryptococcal Meningitis in Adults Living With Human Immunodeficiency Virus: Systematic Review and Meta-Analysis of Diagnostic Test Accuracy Studies

Cryptococcal meningitis (CM), a life-threatening systemic, opportunistic fungal infection, occurs mainly in patients with defective cellular immunity. Cryptococcal antigen (CrAg) detection could direct the timely initiation of antifungal therapy.

Active case‐finding in contacts of people with TB

Exposure to people with TB substantially elevates a person’s risk of tuberculous infection and TB disease. Systematic screening of TB contacts enables the early detection and treatment of co-prevalent disease, and the opportunity to prevent future TB disease.

Determining the value of TB active case-finding: current evidence and methodological considerations

Active case-finding (ACF) is an important component of the End TB Strategy. However, ACF is resource-intensive, and the economics of ACF are not well-understood. Research is essential to the optimal implementation, cost-effectiveness, and affordability of ACF in high-burden settings.

Epidemiology of Healthcare-Associated Infections in Australia

This is Australia’s first peer-reviewed evidence-based assessment of the epidemiology of HAIs using publicly available data from hospital-acquired complications (HACs) state-based surveillance systems and peer-reviewed and grey literature sources.

The Model Crisis, or how to have critical promiscuity in the time of Covid-19

During the past forty years, statistical modelling and simulation have come to frame perceptions of epidemic disease and to determine public health interventions that might limit or suppress the transmission of the causative agent. The influence of such formulaic disease modelling has pervaded public health policy and practice during the Covid-19 pandemic.